Cargando…

Evaluation of transanal hemorrhoidal dearterialization: a single surgeon experience

BACKGROUND: There is an increasing, though still limited, amount of evidence describing the use of the transanal hemorrhoidal dearterialization (THD) device for the treatment of hemorrhoidal disease. This study assesses postoperative outcomes from a single surgeon experience with the THD device. MET...

Descripción completa

Detalles Bibliográficos
Autores principales: LaBella, G. D., Main, W. P. L., Hussain, L. R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4369582/
https://www.ncbi.nlm.nih.gov/pubmed/25637412
http://dx.doi.org/10.1007/s10151-015-1269-6
_version_ 1782362770439667712
author LaBella, G. D.
Main, W. P. L.
Hussain, L. R.
author_facet LaBella, G. D.
Main, W. P. L.
Hussain, L. R.
author_sort LaBella, G. D.
collection PubMed
description BACKGROUND: There is an increasing, though still limited, amount of evidence describing the use of the transanal hemorrhoidal dearterialization (THD) device for the treatment of hemorrhoidal disease. This study assesses postoperative outcomes from a single surgeon experience with the THD device. METHODS: From January 2009 to December 2011, 108 THD procedures were performed. With Doppler guidance, the THD device makes possible precise ligation of the branches of the superior hemorrhoidal artery. Patients were seen postoperatively at 3 weeks and 6 months. They underwent physical examination to determine whether there was recurrence of hemorrhoidal prolapse. They were asked to describe any bleeding, to rate pain using the visual analog scale, and to rate their level of satisfaction on a scale of 1–5 (with 5 = highly satisfied). A phone interview was used for follow-up at 1 year to determine the rate of recurrent prolapse. RESULTS: Of the 108 patients who underwent THD, two were lost to follow-up and excluded. All of the remaining 106 patients completed follow-up at 3 weeks and 6 months. At 3 weeks, 92 % of patients had no pain and 88 % were highly satisfied with the procedure at 3 weeks. This increased to 92 % satisfaction at 1 year. Prolapse recurrence was 7.5 % at 6 months and 10.3 % at 1 year. Bleeding was the most common complication, but did not require re-intervention or transfusion. CONCLUSIONS: THD is a same-day procedure for the treatment of hemorrhoidal disease that is safe and effective, and offers the potential for immediate return to normal activity.
format Online
Article
Text
id pubmed-4369582
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Springer Milan
record_format MEDLINE/PubMed
spelling pubmed-43695822015-03-26 Evaluation of transanal hemorrhoidal dearterialization: a single surgeon experience LaBella, G. D. Main, W. P. L. Hussain, L. R. Tech Coloproctol Original Article BACKGROUND: There is an increasing, though still limited, amount of evidence describing the use of the transanal hemorrhoidal dearterialization (THD) device for the treatment of hemorrhoidal disease. This study assesses postoperative outcomes from a single surgeon experience with the THD device. METHODS: From January 2009 to December 2011, 108 THD procedures were performed. With Doppler guidance, the THD device makes possible precise ligation of the branches of the superior hemorrhoidal artery. Patients were seen postoperatively at 3 weeks and 6 months. They underwent physical examination to determine whether there was recurrence of hemorrhoidal prolapse. They were asked to describe any bleeding, to rate pain using the visual analog scale, and to rate their level of satisfaction on a scale of 1–5 (with 5 = highly satisfied). A phone interview was used for follow-up at 1 year to determine the rate of recurrent prolapse. RESULTS: Of the 108 patients who underwent THD, two were lost to follow-up and excluded. All of the remaining 106 patients completed follow-up at 3 weeks and 6 months. At 3 weeks, 92 % of patients had no pain and 88 % were highly satisfied with the procedure at 3 weeks. This increased to 92 % satisfaction at 1 year. Prolapse recurrence was 7.5 % at 6 months and 10.3 % at 1 year. Bleeding was the most common complication, but did not require re-intervention or transfusion. CONCLUSIONS: THD is a same-day procedure for the treatment of hemorrhoidal disease that is safe and effective, and offers the potential for immediate return to normal activity. Springer Milan 2015-01-31 2015 /pmc/articles/PMC4369582/ /pubmed/25637412 http://dx.doi.org/10.1007/s10151-015-1269-6 Text en © Springer-Verlag Italia Srl 2015
spellingShingle Original Article
LaBella, G. D.
Main, W. P. L.
Hussain, L. R.
Evaluation of transanal hemorrhoidal dearterialization: a single surgeon experience
title Evaluation of transanal hemorrhoidal dearterialization: a single surgeon experience
title_full Evaluation of transanal hemorrhoidal dearterialization: a single surgeon experience
title_fullStr Evaluation of transanal hemorrhoidal dearterialization: a single surgeon experience
title_full_unstemmed Evaluation of transanal hemorrhoidal dearterialization: a single surgeon experience
title_short Evaluation of transanal hemorrhoidal dearterialization: a single surgeon experience
title_sort evaluation of transanal hemorrhoidal dearterialization: a single surgeon experience
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4369582/
https://www.ncbi.nlm.nih.gov/pubmed/25637412
http://dx.doi.org/10.1007/s10151-015-1269-6
work_keys_str_mv AT labellagd evaluationoftransanalhemorrhoidaldearterializationasinglesurgeonexperience
AT mainwpl evaluationoftransanalhemorrhoidaldearterializationasinglesurgeonexperience
AT hussainlr evaluationoftransanalhemorrhoidaldearterializationasinglesurgeonexperience